Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Header
Newsroom
Showing 386 results
February 2016
-
Story Discovery
Leveraging the liver’s ability to heal scarred tissue
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
-
Story From Our Labs
Opening chemistry education to the world
Novartis taps MOOC technology to share chemistry education with the world
-
Story Discovery
Neuroscientists restore cell-to-cell signaling and sociability in autism models
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
-
Story Discovery
Novartis and Pfizer join forces to upend oncology dogma
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
January 2016
-
Story Discovery
Rare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
-
Story From Our Labs
How to address the culture gap between academia and industry in biomedicine
Experts call for significant changes to facilitate the discovery of new treatments.
November 2015
-
Story Access to Healthcare
Bringing modern medicine to rural Vietnam
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
-
Story From Our Labs
Giraffes have high blood pressure. Why don’t they drop dead?
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
October 2015
-
Story Discovery
Stepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
-
Story Discovery
Compounds spur insulin-producing cells to replicate in the lab
-
Story Discovery
Clinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
-
Story Access to Healthcare
Delivering access: first launch in Kenya
Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.